selenocysteine has been researched along with plumbagin in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Guo, J; Ma, K; Ma, Q; Sun, S; Xu, J; Xu, W; Yang, R; Yang, Y; Zhang, J; Zhang, Y | 1 |
1 other study(ies) available for selenocysteine and plumbagin
| Article | Year |
|---|---|
Plumbagin reduction by thioredoxin reductase 1 possesses synergy effects with GLUT1 inhibitor on KEAP1-mutant NSCLC cells.
Topics: Animals; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Survival; Glucose Transporter Type 1; Humans; Kelch-Like ECH-Associated Protein 1; Lung Neoplasms; Naphthoquinones; NF-E2-Related Factor 2; Pyrazoles; Quinolines; Rats; Reactive Oxygen Species; Selenocysteine; Thioredoxin Reductase 1 | 2022 |